1
|
Netti VA, Iovane AN, Vatrella MC, Magnani ND, Evelson PA, Zotta E, Fellet AL, Balaszczuk AM. Dehydration affects cardiovascular nitric oxide synthases and caveolins in growing rats. Eur J Nutr 2014; 55:33-43. [DOI: 10.1007/s00394-014-0820-y] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2014] [Accepted: 12/10/2014] [Indexed: 01/08/2023]
|
2
|
Perticone F, Maio R, Perticone M, Miceli S, Sciacqua A, Tassone EJ, Shehaj E, Tripepi G, Sesti G. Endothelial dysfunction predicts regression of hypertensive cardiac mass. Int J Cardiol 2013; 167:1188-92. [DOI: 10.1016/j.ijcard.2012.03.138] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2011] [Revised: 03/04/2012] [Accepted: 03/14/2012] [Indexed: 11/15/2022]
|
3
|
Bourque SL, Whittingham HA, Brien SE, Davidge ST, Adams MA. Role of endothelin-1 in the hyper-responsiveness to nitrovasodilators following acute NOS inhibition. Br J Pharmacol 2012; 165:1992-1999. [PMID: 21951225 DOI: 10.1111/j.1476-5381.2011.01696.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND AND PURPOSE Acute NOS inhibition in humans and animals is associated with hypersensitivity to NO donors. The mechanisms underlying this phenomenon have not been fully elucidated. The purpose of the present study was to assess whether hypersensitivity to NOS-blockade is linked to endothelin-1 (ET-1) signalling. EXPERIMENTAL APPROACH Sprague Dawley rats were instrumented with indwelling arterial and venous catheters for continuous assessments of haemodynamic parameters and drug delivery, respectively. Mesenteric arteries were isolated and tested for reactivity by wire myography. KEY RESULTS NOS blockade with L-N(G)-nitroarginine methyl ester (L-NAME) caused a pronounced increase in arterial blood pressure (BP) (∼40 mmHg). In L-NAME-treated animals, the dose of sodium nitroprusside (SNP) required to cause a significant reduction in arterial BP was lower than in vehicle-treated rats (P < 0.001), and the magnitude of the reduction in BP was greater. Similar results were obtained with other NO mimetics, but not isoprenaline; moreover, decreasing the BP back to baseline levels with prazosin after L-NAME treatment did not attenuate the hyper-responsiveness to NO donors. The increased responsiveness to NO donors was abolished by pretreatment with the ET(A/B) receptor antagonist, PD145065, or the ET(A) receptor-specific antagonist ABT627. Ex vivo, L-NAME treatment potentiated the constriction induced by big endothelin-1 (bET-1), the precursor to active ET-1, but had no effect on the ET-1-mediated constriction. CONCLUSIONS AND IMPLICATIONS These data suggest that the increased sensitivity to NO donors is mediated, at least in part, by ET-1 in vivo, and the mechanism may involve the conversion of bET-1 to ET-1.
Collapse
Affiliation(s)
- Stephane L Bourque
- Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, CanadaDepartment of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada
| | - Heather A Whittingham
- Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, CanadaDepartment of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada
| | - Susan E Brien
- Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, CanadaDepartment of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada
| | - Sandra T Davidge
- Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, CanadaDepartment of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada
| | - Michael A Adams
- Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, CanadaDepartment of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada
| |
Collapse
|
4
|
Changes critical to persistent lowering of arterial pressure in spontaneously hypertensive rat occur early in antihypertensive treatment. J Hypertens 2011; 29:113-22. [PMID: 20871411 DOI: 10.1097/hjh.0b013e32833fb7cb] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
OBJECTIVES Angiotensin-converting enzyme inhibition (ACEI) in adult spontaneously hypertensive rats (SHRs) produces reductions in mean arterial pressure (MAP) and vascular structure that persist after treatment cessation. This study used an intermittent treatment strategy to determine the time course of changes in MAP, vascular resistance properties, and the tissue levels of endothelin. METHODS Adult SHRs were treated with enalapril and low sodium diet for three 2-week treatment cycles, each separated by 2-week washout periods. MAP was measured via radiotelemetry. Hindlimb structurally based vascular resistance properties were assessed after two treatment cycles. Endothelin was measured in mesenteric vessels, renal cortex and medulla in untreated SHR (Con), and at day 10 of the first and third treatment cycles. RESULTS Treatment produced a persistent reduction in MAP; however, the magnitude of change in the 'off-treatment' level decreased following successive treatments (cycle 1: -15 ± 1.7%, cycle 2: -8 ± 1.9%, and cycle 3: -1 ± 1.7%). Reduction in hindlimb vascular structure after two cycles of treatment was not different from that previously observed after one cycle. Endothelin levels were significantly elevated during the third cycle in renal medulla (Con: 797 ± 102 pg/g tissue, cycle 1: 767 ± 81 pg/g tissue, cycle 3: 1097 ± 205 pg/g tissue) and mesenteric vessels (Con: 711 ± 226 pg/g tissue, cycle 1: 696 ± 231 pg/g tissue, cycle 3: 1063 ± 741 pg/g tissue). Concomitant treatment with an endothelin antagonist did not impact arterial pressure. CONCLUSION These findings demonstrate that during ACEI treatment, most of the changes that confer persistent changes in MAP and vascular structure occur within the first 2 weeks. Elevation in endothelin levels is likely unrelated to arterial pressure.
Collapse
|
5
|
Bourque SL, Benjamin CD, Adams MA, Nakatsu K. Lack of hemodynamic effects after extended heme synthesis inhibition by succinylacetone in rats. J Pharmacol Exp Ther 2010; 333:290-6. [PMID: 20071481 DOI: 10.1124/jpet.109.162966] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Hypertyrosinemia (HT) is a life-threatening condition caused in large part by the buildup of tyrosine metabolites and their derivatives. One such metabolite is succinylacetone (SA), a potent irreversible inhibitor of heme biosynthesis. Heme is a key component of numerous enzymes involved in arterial blood pressure (BP) regulation, including nitric-oxide synthase (NOS) and its downstream mediator soluble guanylyl cyclase (sGC). Because NOS and sGC are important regulators of cardiovascular function, we hypothesized that inhibition of heme supply to these enzymes by SA would result in the induction of a measurable hypertensive response. Male Sprague-Dawley rats were treated with SA (80 mg x kg(-1) x day(-1) i.p.) for 14 days, resulting in a marked increase in urinary SA and delta-aminolevulinic acid (P < 0.001 for both parameters) and decreased heme concentrations in kidney, liver, spleen, and vascular tissues (P < 0.05 for all parameters). After SA treatment, systemic nitrite/nitrate excretion was reduced by 72% (P < 0.001), and renal NOS and sGC activities were decreased by 32 (P < 0.05) and 38% (P < 0.01), respectively. SA administration also compromised the ex vivo sensitivity of aorta to endothelium-dependent and -independent vasodilation. Despite these effects, SA treatment failed to induce any changes in BP, as assessed by radiotelemetry. Moreover, BP profiles in the SA-treated animals were less responsive to altered sodium intake. The present results demonstrate that extended inhibition of heme synthesis with SA affects hemoenzyme function, albeit without consequent effects on BP regulation and sodium excretion.
Collapse
Affiliation(s)
- Stephane L Bourque
- Department of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada
| | | | | | | |
Collapse
|
6
|
Olatunji L, Soladoye A. Oral contraceptive administration aggravates nitric oxide synthesis inhibition-induced high blood pressure in female rats. PATHOPHYSIOLOGY 2008; 15:221-6. [DOI: 10.1016/j.pathophys.2008.09.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2008] [Revised: 06/07/2008] [Accepted: 09/02/2008] [Indexed: 10/21/2022] Open
|
7
|
Woolard J, Hale TM, Bushfield TL, Adams MA. Persistent lowering of arterial pressure after continuous and intermittent therapy. J Hypertens 2003; 21:813-20. [PMID: 12658029 DOI: 10.1097/00004872-200304000-00026] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE The present study investigates the impact of antihypertensive treatment on persistent reduction of arterial pressure after cessation of drug treatment. DESIGN AND METHODS Specifically, adult spontaneously hypertensive rats (SHR) were treated for 6 weeks with inhibitors of the renin-angiotensin system (RAS), or combination therapy (hydralazine, nifedipine, hydrochlorothiazide) and following a 14-week 'drug holiday', were re-treated for 4 weeks. Mean arterial pressure (MAP) was continuously monitored via radiotelemetry. RESULTS Comparison in the first off-treatment period revealed that RAS inhibitor drugs produced a 16-18% persistent lowering of arterial pressure, whereas the triple therapy induced a 10% lowering of MAP relative to untreated SHR. The drug re-challenge induced a further 9% reduction in the 'off'-treatment level of MAP such that in all treatment groups MAP was reduced by more than 30 mmHg compared with controls. CONCLUSIONS This study provides new evidence that combination therapy, not directly targeting the RAS, can be efficacious in persistently reducing MAP off-treatment. Furthermore, we demonstrated that the 6-week treatment with RAS inhibitors induced equivalent persistent changes as a 10-week treatment. That is, the additional 4 weeks of continuous therapy was ineffective in further altering the off-treatment MAP. In contrast, with the intermittent treatment protocol (the 14-week 'drug holiday') a further effect on persistent lowering of MAP was regained. These findings suggest continuous long-term treatment with antihypertensive drugs may not be the most effective means of reversing underlying circulatory abnormalities and that the introduction of a drug holiday may be beneficial.
Collapse
Affiliation(s)
- Jeanette Woolard
- Department of Pharmacology and Toxicology, Queen's University, Kingston, Ontario, Canada
| | | | | | | |
Collapse
|
8
|
Suo M, Kalliovalkama J, Pörsti I, Jolma P, Tolvanen JP, Vuolteenaho O, Ruskoaho H. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism. J Cardiovasc Pharmacol 2002; 40:478-86. [PMID: 12198334 DOI: 10.1097/00005344-200209000-00017] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
This study examined the role of angiotensin II in the increase of blood pressure, activation of cardiac natriuretic peptide gene expression, left ventricular hypertrophy, and vascular changes in nitric oxide-deficient hypertension. N(G)-nitro->L-arginine methyl ester (>L-NAME, 20 mg/kg/d), angiotensin II type 1 receptor (AT ) antagonist losartan (20 mg/kg/d), or their combination were administered orally for 8 weeks in Wistar rats. >L-NAME elevated systolic blood pressure, which reached its maximum within 4 weeks (200 +/- 4 mm Hg). Despite hypertension, >L-NAME administration for 8 weeks did not induce left ventricular hypertrophy. Losartan treatment significantly decreased the development of hypertension induced by >L-NAME and decreased left ventricular hypertrophy in untreated rats. In contrast, losartan did not prevent the hypertrophic remodeling of the mesenteric resistance arteries induced by >L-NAME. >L-NAME treatment increased ventricular atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) mRNA levels and immunoreactive BNP levels significantly. Losartan therapy decreased the >l-NAME-induced ventricular ANP gene expression by 69% (p < 0.05) and also reduced ventricular BNP mRNA levels so that it did not differ from control. Losartan treatment alone decreased ventricular immunoreactive ANP and BNP levels by 30% (p < 0.05). These results show that ventricular ANP and BNP gene expression are dissociated from the increased ventricular mass in nitric oxide deficiency-induced hypertension. Results suggest that >l-NAME-induced hypertension and the associated activation of ventricular ANP and BNP gene expression are, at least in part, mediated by angiotensin II, whereas the resistance vessel hypertrophy following nitric oxide synthase inhibition is angiotensin II independent.
Collapse
Affiliation(s)
- Maria Suo
- Department of Pharmacology, University of Oulu, Finland
| | | | | | | | | | | | | |
Collapse
|
9
|
|
10
|
Hale T, Okabe H, Bushfield T, Heaton J, Adams M. Recovery of Erectile Function after Brief Aggressive Antihypertensive Therapy. J Urol 2002. [DOI: 10.1016/s0022-5347(05)64919-1] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- T.M. Hale
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| | - H. Okabe
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| | - T.L. Bushfield
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| | - J.P.W. Heaton
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| | - M.A. Adams
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| |
Collapse
|
11
|
Jäger D, Müller-Werdan U, Pönicke K, Holtz J, Werdan K, Müller SP. The impact of insulin-like growth factor-1 on the pattern of cardiac elongation factor-2 variants in a model of overload. Mol Cell Biochem 2002; 229:25-34. [PMID: 11936844 DOI: 10.1023/a:1017982724938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Because of its key role in proteosynthesis, the total content of elongation factor-2 (EF-2) and the distribution of six main EF-2 variants were investigated after Pseudomonas Exotoxin A catalyzed [37P]ADP-ribosylation using 1D-PAGE and isoelectric focusing (IEF) in a rat model of hemodynamic overload with variable degrees of cardiac hypertrophy: Chronic NO-synthase inhibition by L-NAME (N-omega-nitro-L-arginine-methyl-ester; 0.75 mg/ml drinking water) induced arterial hypertension without hypertrophy but myocardial apoptosis; additional treatment with IGF-1 (osmotic micropumps) did not modify hypertension but reduced apoptosis allowing moderate hypertrophy of the left ventricles. Total EF-2 did not significantly increase in rats with hemodynamic overload with or without IGF-1 supplementation. A positive correlation was found between an acidic EF-2 variant and apoptosis (p = 0.01). Hypertrophy under additional IGF-1 was combined with a shift of the EF-2 variants to basic subtypes (p < 0.01). This finding may be indicative of the trophic potency of IGF-1.
Collapse
Affiliation(s)
- Doris Jäger
- Department of Mediicne III, Martin-Luther-University, Halle-Wittenberg, Germany.
| | | | | | | | | | | |
Collapse
|
12
|
HALE T, OKABE H, HEATON J, ADAMS M. ANTIHYPERTENSIVE DRUGS INDUCE STRUCTURAL REMODELING OF THE PENILE VASCULATURE. J Urol 2001. [DOI: 10.1016/s0022-5347(05)66053-3] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- T.M. HALE
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| | - H. OKABE
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| | - J.P.W. HEATON
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| | - M.A. ADAMS
- From the Departments of Pharmacology and Toxicology and Urology, Queen’s University, Kingston, Ontario, Canada, and Department of Urology, Okayama University Medical School, Okayama, Japan
| |
Collapse
|
13
|
Jolma P, Kalliovalkama J, Tolvanen JP, Kööbi P, Kähönen M, Hutri-Kähönen N, Wu X, Pörsti I. High-calcium diet enhances vasorelaxation in nitric oxide-deficient hypertension. Am J Physiol Heart Circ Physiol 2000; 279:H1036-43. [PMID: 10993766 DOI: 10.1152/ajpheart.2000.279.3.h1036] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Because the effects of calcium supplementation on arterial tone in nitric oxide-deficient hypertension are unknown, we investigated the influence of elevating dietary calcium from 1.1 to 3.0% in Wistar rats treated with N(G)-nitro-L-arginine methyl ester (L-NAME; 20 mg. kg(-1). day(-1)) for 8 wk. A high-calcium diet attenuated the development of hypertension induced by L-NAME and abrogated the associated impairments of endothelium-independent mesenteric arterial relaxations to nitroprusside, isoproterenol, and cromakalim. Endothelium-dependent relaxations to acetylcholine during nitric oxide synthase inhibition in vitro were decreased in L-NAME rats and improved by calcium supplementation. The inhibition of cyclooxygenase by diclofenac augmented the responses to acetylcholine in L-NAME rats but not in calcium + L-NAME rats. When hyperpolarization of smooth muscle was prevented by KCl precontraction, the responses to acetylcholine during combined nitric oxide synthase and cyclooxygenase inhibition were similar in all groups. Furthermore, superoxide dismutase enhanced the acetylcholine-induced relaxations in L-NAME rats but not in calcium + L-NAME rats. In conclusion, calcium supplementation reduced blood pressure during chronic nitric oxide synthase inhibition and abrogated the associated impairments in endothelium-dependent and -independent arterial relaxation. The augmented vasorelaxation after increased calcium intake in L-NAME hypertension may be explained by enhanced hyperpolarization and increased sensitivity to nitric oxide in arterial smooth muscle and decreased vascular production of superoxide and vasoconstrictor prostanoids.
Collapse
Affiliation(s)
- P Jolma
- Department of Pharmacological Sciences, University of Tampere, Finland
| | | | | | | | | | | | | | | |
Collapse
|
14
|
Affiliation(s)
- R Zatz
- Renal Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo, São Paulo, Brazil
| | | |
Collapse
|